Support along the way
Resources for women taking Rubraca
Here are tools that you can download to help support you along your treatment journey.
Organizations supporting women, family members, and caregivers impacted by ovarian cancer
AMERICAN CANCER SOCIETY (www.cancer.org)
A comprehensive resource for information, support, and ways to become involved in the fight against cancer
Provides telephone, online, and face-to-face counseling, support groups, education, publications, and financial assistance
Find out about cancer treatment, blogs, and support
NATIONAL CANCER INSTITUTE (www.cancer.gov)
Learn about clinical trials, research, and news
Connect with your family, friends, and other patients who want to share their personal stories
FACING OUR RISK OF CANCER EMPOWERED (FORCE) (facingourrisk.com)
Education, advocacy, and research specific to hereditary breast and ovarian cancer
Join a community to share and learn about ovarian cancer, treatment, and support
NATIONAL OVARIAN CANCER COALITION (NOCC) (www.ovarian.org)
Learn how you can support cancer organizations, get medical information, and find future events
OVARIAN CANCER RESEARCH FUND ALLIANCE (OCRFA) (ocrfa.org)
A support network that connects survivors, women at risk, and caregivers
Adverse reaction: any unexpected or dangerous reaction as a result of taking medication.
Antiemetics/antinausea medication: drugs taken to prevent or treat nausea and vomiting.
Clinical trial: research that is designed to test new medical approaches, such as new medicines, and find out if they work and are safe for people.
Complete response, or CR: absence of signs of cancer as a result of treatment. This does not always mean the cancer has been cured.
Deoxyribonucleic acid (DNA): molecules that tell your cells how to survive and grow.
Disease progression: cancer that continues to grow or spread.
Genes: a set of coded instructions in cells for making new proteins and controlling how cells behave.
Median: the middle point in a range of numbers, half of which are above the middle point and half of which are below it. For example, in the following list of numbers—3, 5, 12—the median is 5.
Objective response rate, or ORR: the proportion of patients with a reduction in tumor size by a predefined amount and for a minimum duration. The FDA has defined ORR as the sum of partial and complete responses.
Partial response, or PR: tests show a decrease in the amount of cancer or tumor size in response to treatment, but the cancer is not completely gone.
Placebo: a substance that does not contain any active medication.
Platinum-based chemotherapy: chemotherapeutic agents containing the metal platinum, which is an important component of some anticancer drugs.
Poly (ADP-ribose) polymerase (PARP) inhibitor: medication that blocks PARP, a protein that helps repair DNA when it becomes damaged. Blocking PARP may help keep cancer cells from repairing their damaged DNA, causing them to die. This may also impact other cells and tissues.
Progression-free survival, or PFS: the length of time during and after a treatment that a person continues to live without the disease getting worse.
Response: therapeutic effect of treatment.
Side effect: a problem that may occur when treatment affects healthy tissues or organs.
Watchful waiting: when an oncologist does not provide medicine but closely watches the disease to see if symptoms appear or change. Watchful waiting is often adopted when the risks of treatment outweigh the benefits. Tests and exams can also be used at this time to monitor the disease.